Clearside Biomedical
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $201 | $492 | $2,330 | $306 |
Gross Profit | 201 | 408 | 2,082 | 157 |
EBITDA | -3,318 | -1,649 | -4,750 | -4,648 |
EBIT | -3,402 | -1,733 | -4,835 | -4,727 |
Net Income | -5,972 | -4,495 | -8,223 | -7,306 |
Net Change In Cash | 201 | 492 | 2,330 | 306 |
Free Cash Flow | -5,480 | -4,729 | -5,830 | -5,698 |
Cash | 6,801 | 9,376 | 13,628 | 20,020 |
Basic Shares | 5,233 | 5,189 | 5,128 | 5,056 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,664 | $8,226 | $1,327 | $29,575 |
Gross Profit | 1,515 | 7,871 | 1,123 | 29,575 |
EBITDA | -24,347 | -23,058 | -29,463 | 554 |
EBIT | -24,573 | -23,125 | -29,608 | 376 |
Net Income | -34,352 | -32,485 | -32,947 | 376 |
Net Change In Cash | 1,664 | 8,226 | 1,327 | 29,575 |
Cost of Revenue | 17,722 | 13,049 | ||
Free Cash Flow | -25,675 | -19,912 | -13,611 | -10,733 |
Cash | 20,020 | 28,920 | 48,418 | 30,436 |
Basic Shares | 4,920 | 4,120 | 4,013 | 3,993 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$1.14 |
2025-06-30 | -$0.87 |
2025-03-31 | -$0.11 |
2024-12-31 | -$0.10 |
